BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7930604)

  • 1. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.
    Kataoka T; Takaku K; Magae J; Shinohara N; Takayama H; Kondo S; Nagai K
    J Immunol; 1994 Nov; 153(9):3938-47. PubMed ID: 7930604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of pH and the number of lytic granules in a CD8+ CTL clone treated with an inhibitor of vacuolar type H(+)-ATPase concanamycin A.
    Kataoka T; Sato M; Kondo S; Nagai K
    Biosci Biotechnol Biochem; 1996 Oct; 60(10):1729-31. PubMed ID: 8987677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.
    Kataoka T; Yamada A; Bando M; Honma T; Mizoue K; Nagai K
    Immunology; 2000 Jun; 100(2):170-7. PubMed ID: 10886392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.
    Kataoka T; Togashi K; Takayama H; Takaku K; Nagai K
    Immunology; 1997 Jul; 91(3):493-500. PubMed ID: 9301542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a series of vacuolar type H(+)-ATPase inhibitors on CTL-mediated cytotoxicity.
    Togashi K; Kataoka T; Nagai K
    Immunol Lett; 1997 Mar; 55(3):139-44. PubMed ID: 9161879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G; Rosen D
    J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
    Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
    J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes.
    Trenn G; Takayama H; Sitkovsky MV
    Nature; 1987 Nov 5-11; 330(6143):72-4. PubMed ID: 3118213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of low molecular weight probes on perforin- and Fas-based killing mediated by cytotoxic T lymphocytes.
    Kataoka T; Taniguchi M; Yamada A; Suzuki H; Hamada S; Magae J; Nagai K
    Biosci Biotechnol Biochem; 1996 Oct; 60(10):1726-8. PubMed ID: 8987676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pore-forming protein in individual cytotoxic T lymphocytes: the effect of senescence provides a probe for understanding the lytic mechanism.
    Horvath JA; Mostowski HS; Okumura K; Bloom ET
    Eur J Immunol; 1992 Oct; 22(10):2649-54. PubMed ID: 1396969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are lytic granules and perforin 1 involved in lysis induced by in vivo-primed peritoneal exudate cytolytic T lymphocytes?
    Berke G; Rosen D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):412-6. PubMed ID: 3493559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
    Berke G; Rosen D; Ronen D
    Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
    Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
    J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
    Rodgers KE; Grayson MH; Ware CF
    J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M; Ohminami H; Yakushijin Y; Arai J; Hasegawa A; Ishida Y; Fujita S
    J Immunol; 1999 May; 162(10):6100-6. PubMed ID: 10229852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes.
    Weren A; Bonnekoh B; Schraven B; Gollnick H; Ambach A
    J Immunol Methods; 2004 Jun; 289(1-2):17-26. PubMed ID: 15251408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.